1 million child deaths AVOIDED in India since 2005

Published On 2017-09-20 03:41 GMT   |   Update On 2017-09-20 03:41 GMT

Toronto: India has avoided about 1 million deaths of children under age five since 2005, driven by significant reductions in mortality from pneumonia, diarrhea, tetanus and measles, according to new research published today.


Nearly three times that number could have been saved if national progress in child health matched that reached in some states, Dr. Prabhat Jha, head of the Centre for Global Health Research of St. Michael's Hospital in Toronto, wrote in today's issue of The Lancet.


A steeper decline in the number of girls dying narrowed a previously observed girl-boy mortality gap, said Dr. Jha, a professor in the Dalla Lana School of Public Health at the University of Toronto. An almost equal number of boys and girls under age five died in 2015.


This research is part of the Million Death Study, one of the largest studies of premature deaths in the world. Dr. Jha is the lead investigator of the survey, based in India, where most deaths occur at home and without medical attention. Hundreds of specially trained census staff in India knocked on doors of more than 1.3 million homes to interview household members about deaths. Two physicians independently examined these "verbal autopsies" to establish the most probable cause of death.


"You get the truth when you knock on doors and talk to parents," said Dr. Jha. "We knocked on the doors of 100,000 homes where children died. If the health system failed these families, they will tell you all about it. These are far more reliable numbers than models or projections from small studies."


The study found a 3.3 percent annual decline in mortality rates of neonates (infants less than one-month-old) and 5.4 percent for those ages one month to 59 months. The declines accelerated starting in 2005 and were fastest between 2010 and 2015, and in urban areas and richer states. Per 1,000 live births, the mortality rates among neonates fell from 45 in 2000 to 27 in 2015. The one-59 month mortality rate fell from 45.2 to 19.6.


Looking at specific causes of death, mortality rates from neonatal tetanus and measles fell by at least 90 percent, neonatal infection and birth trauma fell more than 66 percent. For children ages, one to 59 months, mortality rates from pneumonia and diarrhea fell more than 60 percent.


About 6 million children die around the world each year and progress in reducing that number depends greatly on India, which accounts for about a fifth of the deaths. About 29 million Indian children died between 2000 and 2015. Had the mortality rates of 2000 continued unchanged, about 39 million children would have died.


The authors noted that in the last decade the government of India has modestly increased its traditionally low level of public spending on health. The government launched a program to encourage women to give birth in hospitals and for children to have a second dose of measles vaccine.


Dr. Jha said that to meet the United Nation's Sustainable Development Goals of halving its child mortality rates by 2030, India must maintain its current trajectory for children ages one to 59 months and accelerate declines in neonatal mortality.


Reducing the number of neonatal deaths will require efforts to reduce deaths caused by premature delivery and low birthweights, especially in poorer states, he said. Both are strongly linked to largely modifiable maternal and prenatal factors such as health care during pregnancy, education, nutrition, anemia and tobacco use.


In an accompanying commentary for The Lancet, leading scientists from Bangladesh and Tanzania wrote that the "Million Death Study can be a model for other countries where vital registration systems are still fragmented."

Tags:    
Article Source : EurekAlert

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News